Humanigen (STU:0KB1) Beginning Cash Position : €9.49 Mil (As of Mar. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Humanigen Beginning Cash Position?

Humanigen's Beginning Cash Position for the quarter that ended in Mar. 2023 was €9.49 Mil.

Humanigen's quarterly Beginning Cash Position declined from Sep. 2022 (€47.52 Mil) to Dec. 2022 (€23.34 Mil) and declined from Dec. 2022 (€23.34 Mil) to Mar. 2023 (€9.49 Mil).

Humanigen's annual Beginning Cash Position increased from Dec. 2020 (€0.12 Mil) to Dec. 2021 (€59.95 Mil) and increased from Dec. 2021 (€59.95 Mil) to Dec. 2022 (€66.10 Mil).

Humanigen Beginning Cash Position Historical Data

The historical data trend for Humanigen's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Humanigen Beginning Cash Position Chart

Humanigen Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Beginning Cash Position

Get a 7-Day Free Trial

0.74

0.80

0.12

59.95

66.10

Humanigen Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Beginning Cash Position	Get a 7-Day Free Trial															63.57	65.23	47.52	23.34	9.49

Humanigen Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Humanigen Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Humanigen's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Humanigen (STU:0KB1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Humanigen Inc (STU:0KB1) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

830 Morris Turnpike, 4th Floor, Short Hills, NJ, USA, 07078

Website

https://www.humanigen.com

Humanigen Inc is a biopharmaceutical company engaged in the development of proprietary monoclonal antibodies for various oncology indications and to enhance T-cell therapies, making these treatments safer and cost-effective. It focuses on preventing the serious and potentially life-threatening side effects associated with chimeric antigen receptor T-cell (CAR-T) therapy. Its pipeline includes programs such as Lenzilumab, Ifabotuzumab, and HGen005. It has one segment, which is related to the development of pharmaceutical products.

Humanigen (STU:0KB1) Headlines

No Headlines